Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/43159
Title: Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial
Authors: MEEKERS, Evelyne 
DAUW, Jeroen 
MARTENS, Pieter 
Dhont, S
Verbrugge, FH
NIJST, Petra 
ter Maaten, JM
Damman, K
Mebazaa, A
Filippatos, G
Ruschitzka, F
Tang, WHW
Dupont, M
MULLENS, Wilfried 
Issue Date: 2023
Publisher: OXFORD UNIV PRESS
Source: EUROPEAN HEART JOURNAL, 44 (37) , p. 3672 -3682
Abstract: In the ADVOR trial, acetazolamide improved decongestion in acute decompensated heart failure (ADHF). Whether the beneficial effects of acetazolamide are consistent across the entire range of renal function remains unclear.
Keywords: Acute heart failure;acetazolamide;decongestion;kidney function;worsening renal function
Document URI: http://hdl.handle.net/1942/43159
ISSN: 0195-668X
e-ISSN: 1522-9645
DOI: 10.1093/eurheartj/ehad557
ISI #: 001062835800001
Rights: The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Renal function and decongestion with acetazolamide in acute decompensated heart failure_ the ADVOR trial.pdfPublished version815.27 kBAdobe PDFView/Open
Show full item record

WEB OF SCIENCETM
Citations

18
checked on Aug 9, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.